8
Shared Docs
8
Same-Page
8 / 8
Mentions
th end t&ed income values EFTA00811511 Purchase Quantity 4/30/17 5/31117 Unrealized Asset Description Date Cost Value Value Gain (Loss) Southern Financial LLC - Equities (DB) Akom Inc. 6/10/15 5,000 234.206 167,250 166,350 -67.856 Alibabe Group 6/10/15 5,000 444,749 577,500 612,300 167.551 Allianz SE AD
000 275,655 124,785 -1.375.215 Avalanche Ellotedinoisgles now called Adverum Biotechnologles 4/20/15 10,000 298.806 28,500 25,500 -373,106 BASF ADR 4/13/15 5000 508,056 486,430 472,250 -35.806 Bank of New York Mellon 6/25/14 250,000 9.076,406 11,765,000 11,780.000 2,703.594 Biogen I
h end fixed income values EFTA00811550 Purchase Quantity 6/30/17 7131117 Unrealized Asset Description Date Cost Value Value Gain (Loss) Southern Financial LLC - Equities (DB) Akom Inc. 8/10/15 5,000 167,700 - 0 Alibaba Group 6110115 5,000 444.749 704,500 774,750 330.001 AIDanz SE ADR 4/13/15 5,000 90,
0,000 151,575 164,970 -1.335.030 Avalanche Blotechnologies now called Adverum Blotechnologles 4/20/15 10,000 398,606 25 030 25500 -373.106 BASF ADR 4/13/15 5,000 508,056 466,450 476.350 -31,708 Bank of New York Mellon 6/25/14 250,000 12,755,000 0 Biogen Idec Inc 2114/12 2,095 250,4
341/15 5.000. ... __._254,306 15000 155825 157,250 ___156.6Q3 •97,0561 7.1.0.7aW1 Wadomtree Investments Inc 3.24.158 _•,• • 152,9.5P Total Southern Financial LLC - Equities (DB) 58,293,977 79,243,099 64,449,372 6,155,395j Southern Trust Co. - Equities (Mogan Stanley) • Barclays PLC ADR 711.116 100,000 805,008 1
500.000 151.575 164,970 -1.335.030 Avalanche Biotechnoiegles now called Adverum Beledinolcoes 4120115 10000 398,606 25,000 25500 -373,108. BASF ADR 4/13/15 ‘000 508,056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250,000 9,076 406 12,755,000 - -9,076 408 Biogen Idec Inc
MUNI income auras EFTA00811542 Purchase Quantity I 6/30117 7131117 I Unrealized Asset Description Date Cost Value Value I Gain (Loss) Southern Financial LLC - Equities (DB) Akorn Inc. Akbaba Group Allianz SE ADR 6/10/15. "-- 6/10/15 4/13/15 5.000 234.205 5.000 444.749 5.000 90.056 fa:VW- 704.500 98.87
51.575 164,970 -1,335.030 1,50000 Avalanche Biotechnologies now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Id
ells tired income YAWS 1 EFTA00811533 Purchase Quantity 6131117 6/30117 Unrealized Asset Description Date Cost Value Value Gain (Loss) Southern Financial LLC - Equities (DO) Akorn Inc 6/10/15 5 000 234.206 166,350 167,700 -66,506 Alibaba Group 6110/15 5:000 444.749 612,300 704,500 259.751 Allianz SE AD
.500.000 124,785 151,575 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10 000 398,606 25500 25,000 -373 606 -41,606 BASF ADR 4/13/15 5000 508,056 472,250 486,450 Bank of New York Mellon 6/25/14 2517,000 9,076,406 11,780,000 12,755,000 3,678594 318.044 Blogen I
6 81,642,786 1,498,244 EFTA00811670 Purchase Quantity 12/31117 1131/18 Unrealized Asset Description Date Cost Value Value Gain (Loss) Southern Financial LLC - Equities (DB) Advanced Micro Devices (received 0.70 from selling puts) 9115117 20,000 246,012 205,600 274,800 28,788 Advanced Micro Devices (received
o Global Management 3/31/11 263,157 4,999,983 8,807,865 9,407,863 4,407,880 Broadcom Ltd 10/13/17 4,000 985,931 1,027,600 992,120 6,189 BASF ADR 4/13/15 5,000 508,056 549,400 586,000 77,944 Blogen Idec Inc 2/14/12 2,095 250.455 667,404 728.662 478,207 Centene Corp W8/14 15,550
,947 80,123,947 792,604 EFTA00811709 Purchase Quantity 3/31/18 4/30/18 Unrealized Asset Description Date Cost Value Value Gain (Loss) Southern Financial LLC - Equities (DB) Advanced Micro Devices 12/15/17 50,000 612,925 502,500 544,000 -68,925 Amazon 4/2/18 1,000 1.395,441 1,568,130 170,689 Alibaba Gro
/17 314,000 53,321,627 52,682,920 51,891,640 -1,429.987 Apollo Global Management 3/31/11 263.157 4.999.983 7.794.710 7.589,448 2.589.465 BASF ADR 4/13/15 5,000 508,056 507,800 521,000 12,944 Berkshire Hathaway 2/5/18 6 1,852.362 1,794,600 1,743,900 -108,482 Berkshire Hathaway 312
MUNI income auras EFTA00599620 Purchase Quantity I 6/30117 7131117 I Unrealized Asset Description Date Cost Value Value I Gain (Loss) Southern Financial LLC - Equities (DB) Akorn Inc. Akbaba Group Allianz SE ADR 6/10/15. "-- 6/10/15 4/13/15 5.000 234.205 5.000 444.749 5.000 90.056 fa:VW- 704.500 98.87
51.575 164,970 -1,335.030 1,50000 Avalanche Biotechnologies now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Id
Entities connected to both Southern Financial LLC - Equities and BASF ADR

Jeffrey Epstein
PERSON
Gilead Sciences Inc
ORGANIZATIONCredit Suisse Group
ORGANIZATION
Prince Charles
PERSON
Barclays
ORGANIZATIONSouthern Trust Co. - Fixed
ORGANIZATIONSouthern Cal Edison
ORGANIZATIONSeaspan
LOCATIONCharles Schwab
PERSON
Volkswagen AG
ORGANIZATION
JPMorgan Chase
ORGANIZATIONFoundation Medicine Inc
ORGANIZATIONSouthern Trust Co. - Equities
ORGANIZATIONPrytanee LLC
ORGANIZATIONIGO LLC
ORGANIZATIONBoothbay Multi-Strategy Fund
ORGANIZATIONON Semiconductor
ORGANIZATIONSequential Brands
ORGANIZATIONGratitude America, LTD - Equities
ORGANIZATION